Phase 1 study of the pharmacokinetics and clinical proof-of-concept activity of a biofilm-disrupting human monoclonal antibody in patients with chronic prosthetic joint infection of the knee or hip.
Janet ConwayRonald E DelanoisMichael A MontAlexandra StavrakisEdward McPhersonEdward StolarskiStephen IncavoDaniel OakesRalph SalvagnoJohn S AdamsAdriane Kisch-HancockEdgar TenorioAnton LeightonStefan RyserLawrence M KauvarNicholas M BernthalPublished in: Antimicrobial agents and chemotherapy (2024)
This study is registered with ClinicalTrials.gov as NCT04763759.